Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

This study has been completed.
Information provided by (Responsible Party):
ViroMed Co., Ltd. dba VM BioPharma Identifier:
First received: February 4, 2010
Last updated: October 14, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 16, 2015